Category: Vaccine

Page 67«..1020..66676869..8090..»

Joplin Health Dept. passes audit on Vaccines for Children Program Newstalk KZRG – NewsTalk KZRG

April 6, 2024

During the visit, staff and processes are reviewed to ensure full compliance is being met according to the programs standards. Various categories of the review include all VCF providers:

Vaccinations are among the most effective tools in our public health toolbox, said Ryan Talken, Director of Joplins Health Department. Vaccines have greatly reduced diseases, and in some cases, eliminated instances of certain diseases.

The Medical Division of the Health Department manages the Vaccine For Children.

Joplin Health nurses work with businesses, schools, and other locations throughout the year to offer vaccinations in convenient locations to those seeking them. They also lead numerous vaccination clinics as parents prepare for school enrollment.

For more information about the Joplin Health Departments Vaccination for Children Program, call 417-623-6122, ext. 1289.

View original post here:

Joplin Health Dept. passes audit on Vaccines for Children Program Newstalk KZRG - NewsTalk KZRG

Chicago Has Recorded 56 Cases of Measles This Year, More Than Half of the National Total – WTTW News

April 6, 2024

Chicago has seen 56 measles cases this year, accounting for over half of the cases across the country.

The Centers for Disease Control and Prevention also reports more than half of cases are in children under the age of 5.

The Chicago Department of Public Health says they are fighting the spread through testing and vaccinations particularly in the Pilsen migrant shelter where the majority of cases are emerging.

Dr. Brian Borah, medical director for vaccine-preventable diseases at the Chicago Department of Public Health, says their efforts have led 6,000 people receiving vaccinations at 75 different vaccine events since March.

I think we were able to get ahead of the virus in that way, he said. And we really have targeted most of the shelters housing these new arrivals in Chicago and we think have put a good dent in this outbreak.

CDPH has not specified how many cases are from the Pilsen migrant shelter but they have said it is not the source.

Clearly weve had a lot of cases come out of that setting, Borah said. But I think its an open question about how measles came to be in that setting Certainly the measles was in Chicago before this outbreak started. So we think that there are somehow links to one of those two cases or another case that were not sure about, but were still investigating those details.

Children under 5 are considered high risk of becoming very sick

Someone with measles typically starts showing symptoms similar to a cold such as a cough, runny nose or red eyes. A rash, which often starts at the head and moves down to the rest of the body, then signals a measles case.

Measles is one of the most contagious diseases and children under 5 are considered at high risk of becoming very sick from it, according to Borah. But he added vaccination is the key to immunity. If someone is unsure of their vaccination status, a blood test can be used.

Continued here:

Chicago Has Recorded 56 Cases of Measles This Year, More Than Half of the National Total - WTTW News

Sanofi Announces Launch of Verorab (Sanofi Inactivated Rabies Vaccine) in the UK for Pre-exposure and Post … – Yahoo Finance

April 6, 2024

Pre-exposure prophylaxis clinical trials of a 3-dose regimen of Verorab followed by a booster dose at 1 year in adults and children achieved an adequate immune response.1

Of those who had a booster dose at 1 year, 96.9% of vaccinated individuals maintained a protective antibody response for 10 years.1

Post-exposure phase 4 prophylaxis clinical trials showed individuals bitten by animals with rabies and treated with a 5-dose regimen of Verorab were all alive 3 years after post-exposure prophylaxis.1

Adverse reactions were moderate in intensity and most resolved within 1 to 3 days of their onset.1

READING, U.K., April 05, 2024--(BUSINESS WIRE)--Sanofi (EURONEXT: SAN and NASDAQ: SNY) has today announced the launch of Verorab (Sanofi Inactivated Rabies Vaccine) in the UK, an inactivated rabies vaccine indicated for pre-exposure and post-exposure prophylaxis of rabies in all age groups.1

This launch is based on extensive clinical data from over 13,000 individuals.1 Sanofi Inactivated Rabies Vaccine has been approved and widely used in more than 80 countries.2 It is estimated that between 41 and 70 million individuals have received the vaccine since its first licensure in May 1985, in France.2

Rabies is nearly always fatal once symptoms appear, but can be preventable with vaccination3

Each year, an estimated 59,000 people worldwide die from rabies.4 Thats one person every nine minutes of every day3, with approximately 95% of deaths occurring in Asia and Africa.3,4,5 Individuals travelling to these countries should be aware of the risk of rabies and take the appropriate precautionary measures.

Rebecca Catterick, UK and Ireland Sanofi Vaccines General Manager, said:

"Rabies is a fatal, travel-related vaccine-preventable disease. The availability of Verorab in the UK provides an effective immunisation option for those travelling to high-risk countries, as well as a treatment for post-rabies exposure."

Joanna Lowry, Specialist Travel Nurse & Educator, said:

Story continues

"I am always surprised by the number of British travellers I meet who are unaware of the risk of rabies. Increasing awareness and sharing education on preventative measures is crucial to help reduce the possibility of this devastating disease."

Rabies in the UK is extremely rare,6 and the last case of classical rabies acquired in the UK occurred more than a century ago.6

Rabies is primarily transmitted by the bite, scratch, or lick of a rabid animal, 99% of which are by dogs, but can also be other wildlife, such as foxes or bats.6

About Verorab (Sanofi Inactivated Rabies Vaccine)

Sanofi Inactivated Rabies Vaccine is indicated for pre-exposure and post-exposure prophylaxis of rabies in all age groups and should be given according to official recommendations.1 It can be used for both primary and booster vaccination and pre-exposure prophylaxis.1 Post-exposure prophylaxis should be initiated as soon as possible after suspected exposure to rabies, and must be performed before administration of vaccine or rabies immunoglobulins, when they are indicated.1 Pre-exposure vaccination consists of intramuscular (IM) injections of Sanofi Inactivated Rabies Vaccine.1 Post-exposure prophylaxis can be administered via IM or intradermal (ID) routes.1

Most commonly observed side effects include pain at the injection site, a general feeling of discomfort or being unwell (malaise), and headache.1 Injection site reactions (pain, erythema and swelling) were more common after an ID injection than an IM injection.1 Pain was the most common injection site reaction for both administration routes.1

Sanofi Inactivated Rabies Vaccine is available as a lyophilised powder and a solvent (sodium chloride) for suspension for injection, containing inactivated rabies virus, and is available with or without attached needles.1

About Sanofi

We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve peoples lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and potentially life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the centre of our ambitions. Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY.

References

1 Verorab SmpC. November 2023. 2 Sanofi Vaccines. Data on file. 3 WHO. Zero by 30: the global strategic plan to end human deaths from dog-mediated rabies by 2030. Available at: https://iris.who.int/bitstream/handle/10665/272756/9789241513838-eng.pdf?sequence=1. Accessed March 2024. 4 WHO. Rabies vaccines: WHO position paper April 2018. Wkly Epidemiol Rec. 2018;93(16):201-20. 5 WHO. Rabies key facts. September 2023. Available at: https://www.who.int/news-room/fact-sheets/detail/rabies. Accessed March 2024. 6 Gov.UK. Rabies: epidemiology, transmission and prevention. Available at: https://www.gov.uk/guidance/rabies-epidemiology-transmission-and-prevention#:~:text=Human%20rabies%20in%20the%20UK,-Human%20rabies%20is&text=Cases%20occurring%20since%20then%20have,from%20the%20Philippines%20and%20Nigeria. Accessed March 2024.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240404662602/en/

Contacts

Sanaz Ayoughi, UK & Ireland Sanofi Vaccines Communications Lead |+44 (0) 7753 717 109 sanaz.ayoughi@sanofi.com

See the original post:

Sanofi Announces Launch of Verorab (Sanofi Inactivated Rabies Vaccine) in the UK for Pre-exposure and Post ... - Yahoo Finance

Ask The Expert: Have you received your Measles vaccine? – NorthShore Health Centers – The Times of Northwest Indiana

April 6, 2024

Due to the recent measles outbreak in Chicago, IL NorthShore Health Centers wanted to share information regarding the importance of receiving your measles vaccine. Dr. Sankaran also shares what symptoms to watch for if you are unvaccinated.

Visit https://northshorehealth.org/ to view a list of providers available at a convenient location near you providing services to four counties in Northwest Indiana.

Read the original here:

Ask The Expert: Have you received your Measles vaccine? - NorthShore Health Centers - The Times of Northwest Indiana

Rising incidence of hepatitis A in Uzbekistan prompts vaccination push – Gavi, the Vaccine Alliance

April 6, 2024

The incidence of hepatitis A in Uzbekistan has risen steeply in recent months, with a concerning number of children infected with the virus. According to Maftuna Saidova, the head of the Information Service of the Committee for Sanitary and Epidemiological Well-being and Public Health, more than 9,500 children were diagnosed with hepatitis A by early February. The increase in cases has been particularly notable in the Andijan, Bukhara, Namangan, Surkhandaryo, Samarkand and Fergana regions, and in the Republic of Karakalpakstan.

Tashkent resident Nilyufar Sadikova became ill with hepatitis A last year. "I infected the children one by one: the disease manifested itself after 30 days in each child, says Sadikova. No one in the family was vaccinated.

Highly contagious, the hepatitis A virus spreads via direct contact with sick people, or through the ingestion of contaminated food or water. Once in the body, the virus causes an inflammation of the liver, producing symptoms that include fever, malaise, appetite loss, diarrhea and vomiting, abdominal pain and jaundice. Unlike the related hepatitis B and C viruses, hepatitis A does not cause chronic disease but in rare cases it does precipitate acute liver failure, which can be deadly. WHO estimates that more than 7,000 people worldwide died of hepatitis A infections in 2016.

Inactivated hepatitis A vaccines have been available for children older than one year since the early 1990s. After her children got sick, Sadikova says, their school began the process of vaccination against hepatitis A. Sadikova says she regrets that she did not vaccinate her children against this disease earlier.

In Uzbekistan, like in many countries, the hepatitis A vaccine is not included in the national vaccination schedule, meaning that it is not one of the vaccines provided by the state, free of charge. Still, many kindergartens and schools, according to internal rules, require parents to vaccinate their children against this disease privately.

According to the Medek Plus Vaccination Center in Tashkent, the cost of hepatitis A vaccination averages 350,000 Uzbek soms (about US$ 28).

The Ministry of Health of Uzbekistan warned that in neighbouring Kazakhstan, there has also been an increase in cases of hepatitis A infection, and recommended that parents vaccinate especially children aged two years and older, as well as those in contact with them. According to the Ministry of Health of Kazakhstan, that country has registered 850 cases of infection so far this year, which is almost twice as for the equivalent period a year ago.

Uzbek Health officials have emphasised the importance of vaccination in preventing the transmission of the virus, highlighting that vaccination can prevent the spread of the virus in 9498% of cases.

According to paediatrician Diloram Akhrorova, the primary focus of hepatitis A vaccination has been on children aged 18 months to 14 years, with the vaccine providing immunity for up to 15 years following administration. A single dose of the vaccine is considered sufficient, and no additional booster shots are required.

But not all parents welcome the hepatitis A vaccination campaign in schools. Tashkent resident Nodira Akbarova is among the sceptical. After the winter holidays, the school announced that they would vaccinate all primary school children who had not received the vaccine against hepatitis A. But Im not sure I will give my consent to this, says the woman. Akbarova cites her confidence that most cases of this disease end in complete recovery to explain her reluctance to vaccinate.

However, the Ministry of Health of Uzbekistan is warning that for people with weakened immunity and health problems, there is a risk of rapid development of disease with a fatal outcome.

According to the Committee for Sanitary-Epidemiological Welfare and Public Health, in the past year, 365,167 children across the country were vaccinated against hepatitis A. However, despite these vaccination efforts, the increasing incidence of hepatitis A presents a considerable burden on both the population and the health care system.

The experiences of health care facilities and professionals in dealing with the hepatitis A swell underscore the need for heightened awareness, proactive measures and effective management of the disease, said the Committee for Sanitary-Epidemiological Welfare and Public Health.

Controlling the virus will demand a collaborative effort, with participation from state authorities, health workers and the public.

Link:

Rising incidence of hepatitis A in Uzbekistan prompts vaccination push - Gavi, the Vaccine Alliance

Groundbreaking vaccination research shared at World Vaccine Congress – DVM 360

April 6, 2024

Anivive Lifesciences (Anivive) announced it will present the findings from its groundbreaking research on developing a systemic antifungal vaccination, which would be the first worldwide. Anivive will share the findings during the World Vaccine Congress happening April 1-4.

According to the release, Edward Robb, DVM, chief strategy officer at Anivive is leading a team of researchers at Anivive that are collaborating with the Valley Fever Center for Excellence at the University of Arizona.1 The joint efforts have led to the development of a novel vaccine candidate to target coccidioidomycosis fungal infection, commonly referred to as Valley Fever.

Robb will present the findings on behalf of the team and will focus his lecture on the crucial need for an effective antifungal disease, especially considering the increase of fungal infections across the world as well as the challenges faced when developing this kind of vaccination. A study published earlier this year inThe Lancet Infectious Diseasesfound that the global incidence and mortality from invasive fungal diseases is substantially higher than previously thought.2

The study used data collected from 85 papers on individual countries and global disease burden from 2010 to 2023 and estimated that over 6.55 million people are affected by an invasive fungal infection and 3.8 million reported deaths. Researchers of the study also noted that these estimates do not include influenza or COVID-19 outbreaks. Out of those reported deaths, about 68% were directly connected to a fungal infection.2

"We are at a pivotal moment in the fight against fungal infections," said Robb. "The development of an antifungal vaccine represents a transformative approach to combating these pervasive and often overlooked pathogens. I am honored to share our findings at the World Vaccine Congress and contribute to the global dialogue on vaccine innovation."

The research conducted by Robb and his team was a collaborative effort bringing together private and public enterprises to create a significant breakthrough within vaccinology and could lead researchers to become the first to prevent a systemic fungal infection that is common in dogs and humans. Current and traditional treatment options are often long and costly therapies with the risk of relapse as well as drug resistance. A vaccine of this nature can offer an alternative by using the bodys immune system to prevent the infection altogether.

The presentation will give attendees insights into the vaccines mechanisms of action, preclinical studies for efficacy, and the microbial safety of the vaccine.

References

Read more from the original source:

Groundbreaking vaccination research shared at World Vaccine Congress - DVM 360

Vaccine exemption rates and missing measles shots have Utah health officials on guard – KUER 90.1

April 6, 2024

Now that a measles outbreak has hit 18 states, Utah health officials are bracing for what could come.

The potential danger is exacerbated by a sharp decline in vaccination rates among children entering kindergarten, including the measles, mumps and rubella vaccine.

According to the Utah Department of Health and Human Services, kindergarteners exempt from vaccination have hovered at around 5% for a long time. In the last two years, however, that jumped to 7.2%.

Including other factors, like vaccination non-compliance and online schooling, 87.3% of kindergarteners are adequately vaccinated statewide. For herd immunity, health officials look for a 95% vaccination rate.

Rich Lakin, the immunization program director at the Utah Department of Health and Human Services, said misinformation and safety concerns have been large drivers in vaccination rate decreases.

A lot of the exemptions are not because the parents are against vaccinations, Lakin added. It's because they come to school and they're not prepared. And an easy way to get their child enrolled in school right away is to just to claim an exemption.

Exemptions can be claimed for medical, personal or religious reasons. The most common category is personal. Parents only need to click through an online educational module to receive it.

During the 2022-2023 school year, 11.2% of kindergarteners in the Wasatch health district started school without an MMR vaccine. The exemption rate in Wasatch also jumped from 7.1% to 10.9% in just one year.

The numbers that we are seeing are unprecedented, said Aubreigh Parks, the nursing and wellness supervisor for the Wasatch County School District.

She said much of this change came in the aftermath of the pandemic when skepticism about vaccines became commonplace. As a result, Parks sees her role as an educator to combat parents fears surrounding vaccination as crucial.

Parents deserve a health care provider who will sit down with them and have these educated conversations addressing these fears. Parents need help accessing valid, evidence-based guidelines and understanding how that information they've heard or seen is incorrect.

In the meantime, shes worried about the potential for measles cases to pop up in the coming weeks especially with spring break starting next week. Beyond illness, theres the risk of learning loss among students already trying to catch up after the pandemic.

If two connected measles cases are found in the same school, state policy mandates that every student without an MMR vaccine not attend school for at least three weeks.

The exclusion period can go longer than that initial 21 days from exposure because technically they have to stay out depending on how many more cases occur. These students would have to stay out for 21 days after the date of the last known cases measles rash onset, Parks said.

She has never experienced a measles case in the district but at this point all of us in this state, not just Wasatch County School District, are sitting ducks. Were all sitting and watching and waiting for us to be next.

Its heartbreaking because I know that the students education could potentially be impacted by something that's very preventable. And it's heartbreaking because it tells me how much distrust there has been between health care [providers] and patients.

Read the original post:

Vaccine exemption rates and missing measles shots have Utah health officials on guard - KUER 90.1

Bird Flu infects cows, chickens, but risk of spillover to humans is low : Shots – Health News – NPR

April 6, 2024

An outbreak of bird flu is affecting dairy cows in the U.S. Charlie Neibergall/AP hide caption

An outbreak of bird flu is affecting dairy cows in the U.S.

The recent spread of avian influenza in dairy cattle in the U.S. has startled even some scientists who've tracked a global outbreak of the virus over the last few years.

"There's a heap of unknowns right now," says Richard Webby, a virologist at St Jude Children's Research Hospital.

How widespread is the virus in dairy cattle? What could this mean for humans? None of this is clear yet.

The first cases of this H5N1 bird flu strain emerged in North America among wild migratory birds in late 2021 and soon spread to poultry farms. It's now showing up among dairy cows and at a major egg producer and one person who had close contact with cows has been infected.

"This particular version of the H5N1 virus is teaching us that some of the things we thought we knew about flu were wrong," Webby says.

The current outbreak has affected many new wild bird species and persisted for longer than previous ones. The virus has also popped up more often in mammals, both in the wild and on farms, and at times led to a wave of infections and death.

"We are in fairly unprecedented, uncharted territory, globally in relationship to avian influenza," says Dr. Peter Rabinowitz, director of the UW Center for One Health Research.

But federal officials and scientists stress the risk to the public still remains low.

So far, the virus does not appear to have mutated in a way that would make it significantly more dangerous. While concerning, the one human case, they say, is consistent with how people usually catch these viruses, through direct exposure to a sick animal.

But scientists are watching this outbreak closely. Here's more of what they are learning.

While it's still early days, Webby says the genetic sequencing collected from infected cattle hasn't turned up anything that "immediately screams, this virus has changed, and that's why these cows are getting infected."

"It just seems to be fairly typical of the viruses that have been detected in birds in various regions," he says.

Sequencing of the virus in the Texas patient did show "minor changes," including one mutation associated with viral adaptation to mammals that's appeared in other human cases, according to a report from the Centers for Disease Control and Prevention.

However, there's no indication from those previous infections that this mutation makes the virus more likely to spread among humans.

This change does seem to have happened when the virus jumped from a cow to the person, but there's nothing altogether alarming about it, says Angie Rasmussen.

"It doesn't look like there's any indication that this has adapted itself to spread efficiently between humans, and to routinely cause severe disease," says Rasmussen, a virologist at the Vaccine and Infectious Disease Organization at the University of Saskatchewan.

But she says this human case and the infections in dairy cattle are clear warnings: "The less human or cow transmission we have, the fewer of these mutations the virus can acquire."

It's generally rare for people to catch any type of bird flu and human-to-human spread is even rarer.

During the current outbreak, this version of H5N1 has only been detected in a handful of humans in the last few years globally, and there aren't any documeneted cases of human-to-human transmission.

In the Texas case, the person's only symptom was eye redness after being exposed to cattle. It's the second known H5N1 infection of a human in the U.S. In 2022, a poultry worker in Colorado was exposed to sick chickens and developed a mild illness.

Some recent human infections have led to severe illness in other countries, including Ecuador, Chile and China. "This is a virus that doesn't infect humans very well, but can not all the time cause very significant disease when it does."

Historically, human infections with avian influenza were often traced back to close contact with birds, specifically in markets or on farms.

"If you're exposed to bird feces, if you're exposed to dead birds, if you're around a lot of live birds, you're going to be exposed to more of that," says Rasmussen.

Unlike the seasonal influenza viruses that infects humans, H5N1 doesn't have the ability to easily attack our upper respiratory tract, so it doesn't tend to spread among humans.

However, the virus can bind to receptors in the lower respiratory tract. This may be one reason that people who develop respiratory infections with bird flu "can get very, very sick with severe pneumonia because those receptors are located deep in the lungs," says Rasmussen.

Of course, scientists are looking out for any signs that the virus has adapted to better target our upper respiratory tract.

The recent case in Texas also raises the possibility of "mucosal exposure," meaning the person may have come in contact with the virus and then touched their eyes, although the details and what that might mean for tranmission are unclear, she says.

A central question for scientists right now is whether there's significant transmission of the virus between dairy cattle.

Cases have been detected in herds in Texas, Michigan, Kansas and New Mexico, and are suspected in other states, as well.

Evidence suggests infected wild birds may have been the initial source of the infection, but "it's hard to explain exactly what's going on without some degree of mammal-to-mammal spread," says Webby.

Others tracking the outbreak agree.

"The way people are telling me it gets on their farm and moves, I'd be very surprised if this was not being spread from cow to cow," says Joe Armstrong, a veterinarian at the University of Minnesota.

In early February, Armstrong started tracking reports of a mysterious illness in dairy cattle on the Texas panhandle and other states. He says just how many of these cases can be attributed to avian influenza still remains fuzzy.

"If we have wild birds involved and other wildlife, it's almost impossible to keep livestock and wildlife separate completely," he says.

While cows are falling sick, it's not proving to be deadly, says Armstrong. And so far, federal officials emphasize the commercial milk supply is not at risk because products are pasteurized.

Currently it's not clear exactly how bird flu is spreading among mammals, and to what extent infections are mostly happening after some kind of contact with infected birds.

But scientists worry about sustained mammal to mammal transmission of avian influenza because that gives the virus more opportunities to adapt to that host and acquire mutations that could make it better suited to mammals.

There have been large die offs of marine mammals in South America and a particularly alarming outbreak on a mink farm in Spain.

In both of those examples, the virus had evolved a couple of "mammal adaptive mutations" that haven't yet been seen in cows, says Louise Moncla, a virologist at the University of Pennsylvania.

Cows are typically infected by a different type of influenza, so that makes it hard to speculate about the risk posed to humans.

"It's just simply very unusual and very odd," says Moncla.

Unlike pigs known to be intermediary hosts for human and bird viruses there is no data that show that cows are an important intermediary host for these viruses, she says.

An ongoing outbreak in livestock not only threatens the industry, but also makes it more likely that other animals will be exposed, or the workers themselves.

"In general, we have not paid a lot of attention to these workers, even though they've often been sort of like the canary in the coal mine, the first evidence of a transmission event," says Rabinowitz.

Federal health officials stress that they are taking the situation seriously.

'The United States has been preparing for avian flu outbreaks for more than 20 years," CDC director Dr. Mandy Cohen told NPR's All Things Considered. "It's very different from what we experienced, for example, at the beginning of COVID, when we were seeing a brand new novel virus where we didn't have tests, we didn't have treatment and we didn't have vaccine."

The U.S has a limited stockpile of vaccines that were developed for early strains of H5N1 that could be tapped if there's any human-to-human spread.

Immune-stimulating ingredients, known as adjuvants, can be added to these older vaccines in order to broaden the immune response so that it better covers mismatched strains. In addition, mRNA technology could be leveraged to produce new vaccines, says Dr. Wilbur Chen, at the University of Maryland's School of Medicine.

"All of those can be used in a pandemic response," he says,

Chen says part of the ongoing preparation for the possibility of more human cases could include manufacturing limited quantities of vaccines.

Dr. Ashish Jha, dean of Brown University's school of public health, says he would not be surprised if there are more cases in humans, most likely other farm workers.

But he says it's not yet time to start mobilizing a larger pandemic response say, pumping out millions of vaccines because the chances that will be needed are very very low.

"If you are seeing it widespread in farm workers, you want to think about vaccinating farm workers. If you start seeing it in non farm workers with evidence of human-to-human transmission, that's when you start wanting to think about vaccinating a much broader set of the population," he says.

Read the original post:

Bird Flu infects cows, chickens, but risk of spillover to humans is low : Shots - Health News - NPR

European prosecutors take over Belgian probe into Pfizergate – POLITICO Europe

April 6, 2024

Transparency campaigners and some political opponents have sought to put pressure on the Commission to discuss the case, but von der Leyen has so far avoided addressing it. In a reply to a direct question put to her by POLITICO about missing text messages, von der Leyen said: Everything necessary about that has been said and exchanged. And we will wait for the results.

In 2022, EPPO announced it was looking into the EUs vaccine procurement more generally, but this is the first time that the office has been linked with Pfizergate explicitly.

The case now being looked at by EPPO brings together several different legal, political and financial strands and it intersects with lawsuits that pharmaceutical giant Pfizer brought against Hungary and Poland.

Last year, Baldan, a 36-old Belgian lobbyist who is represented by the same lawyer that represents French vaccine-skeptic group Bon Sens, lodged a criminal complaint in Belgium in connection to von der Leyens role in the vaccine negotiations with Pfizer over what he alleges were acts of "interference in public functions, destruction of SMS, corruption and conflict of interest," according to legal information provided by his lawyer.Bon Sens hasput forward its own legal challenges in connection with Pfizergate.

The addition of European governments to his complaint adds weight to what might otherwise have been seen as a personal crusade. Hungary, led by Viktor Orbn, a steadfast opponent of von der Leyen, also filed a complaint in connection to the Commission presidents role in vaccine negotiations with Pfizer, according to two insiders with knowledge of the case, speaking on condition of anonymity because of its sensitivity.

Poland lodged its own complaint last November, a Polish government spokesperson confirmed. However, following the election of Tusk in December, the new government is working [to] withdraw Poland from these proceedings, the spokesperson said.

More here:

European prosecutors take over Belgian probe into Pfizergate - POLITICO Europe

England’s MMR vaccinations up 23% following NHS initiative – Pharmaceutical Technology

April 6, 2024

Englands NHS is calling its recent campaign to boost vaccination rates a success amidst a surge in measles, mumps, and rubella (MMR) cases.

Latest data released by the health service shows that there were 23% more vaccinations in the first quarter of 2024 compared to the same time last year.

A total of 360,964 jabs were delivered between January and March this year, compared to 293,847 in 2023. The biggest jump was seen in those aged five to 25 years old, with vaccinations up four-fold in that group between 2024 and 2023.

In January, the UK Health Security Agency (UKHSA) declared a national incident following a surge in measles outbreaks across Britain. The highly contagious measles virus can cause serious illness and, in some cases, even death, in children and adults. It is also dangerous if caught during pregnancy, potentially resulting in stillbirth, miscarriage, and low birth weight.

In the same month, the NHS started contacting millions of patients and carers in England to book their children in for a catch-up vaccine with a GP. The campaign also targeted those in the 11 to 25 year-age group in areas with low vaccine uptake rates such as London and the West Midlands.

At the time, the NHS said its figures indicated that more than 3.4 million children under 16 years of age were unprotected against the three infectious diseases. There have been 934 confirmed cases of measles in England since the beginning of October last year, according to data from the UKSHA. The West Midlands accounted for around half of the cases seen since January.

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Your download email will arrive shortly

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

Country * UK USA Afghanistan land Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos Islands Colombia Comoros Congo Democratic Republic of the Congo Cook Islands Costa Rica Cte d"Ivoire Croatia Cuba Curaao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Holy See Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati North Korea South Korea Kuwait Kyrgyzstan Lao Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macedonia, The Former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Northern Mariana Islands Norway Oman Pakistan Palau Palestinian Territory Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Runion Romania Russian Federation Rwanda Saint Helena, Ascension and Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Pierre and Miquelon Saint Vincent and The Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and The South Sandwich Islands Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates US Minor Outlying Islands Uruguay Uzbekistan Vanuatu Venezuela Vietnam British Virgin Islands US Virgin Islands Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe Kosovo

Industry * Academia & Education Aerospace, Defense & Security Agriculture Asset Management Automotive Banking & Payments Chemicals Construction Consumer Foodservice Government, trade bodies and NGOs Health & Fitness Hospitals & Healthcare HR, Staffing & Recruitment Insurance Investment Banking Legal Services Management Consulting Marketing & Advertising Media & Publishing Medical Devices Mining Oil & Gas Packaging Pharmaceuticals Power & Utilities Private Equity Real Estate Retail Sport Technology Telecom Transportation & Logistics Travel, Tourism & Hospitality Venture Capital

Tick here to opt out of curated industry news, reports, and event updates from Pharmaceutical Technology.

Submit and download

UKSHA head of immunisation Dr Mary Ramsay said: The big increase in people, especially children, getting their MMR vaccine following our recent marketing campaign on missed immunisations is fantastic to see.

The NHS uses MSDs M-M-RVaxPro and GSKs Priorix for MMR vaccines. The shots were approved for use in the UK in 1997 and 2006, respectively. They are recommended for all babies and young children, with adults able to receive one if unvaccinated.

Two doses of the vaccines are required, resulting in lifelong protection with high efficacy against the three viruses which are easily spread between unvaccinated people.

The World Health Organization (WHO) has said 95% vaccine coverage would eliminate measles in a population completely.

The US has also seen a surge in measles cases, with the Centers for Disease Control and Prevention (CDC) reporting 97 cases in 2024 so far. Over half of the patients diagnosed with the virus were hospitalised. The CDC issued a health alert urging travellers, especially children, to get vaccinated. A statement from the American Medical Association echoed the call for vaccinations. The US also uses MSDs M-M-R II and GSKs Priorix.

Give your business an edge with our leading industry insights.

View original post here:

England's MMR vaccinations up 23% following NHS initiative - Pharmaceutical Technology

Page 67«..1020..66676869..8090..»